AYTU BioPharma, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for AYTU, updated each market day.
AYTU AI Sentiment
AI sees no strong directional signal for AYTU BioPharma, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 30, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About AYTU BioPharma, Inc. Common Stock
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.
Sector
Exchange
Market Cap
$27,047,684
Cap Tier
Employees
83
Headquarters
DENVER, CO
Listed Since
Feb. 15, 2008
Website
AYTU Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
AYTU Volatility
AYTU BioPharma, Inc. Common Stock has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
